Eric Topol/X;
Leslie Skeith/ucalgary.ca; Shannon M. Bates/fwgbd.org
Apr 17, 2026, 14:34
Eric Topol: The Role of Sex Hormones in Venous Thromboembolism and Cardiovascular Disease Risk
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared a post on X about a recent article by Leslie Skeith, published in NEJM:
“Sex hormones, clotting disorders, and cardiovascular risk – An important new NEJM review for MHT and testosterone latest data.”
Title: Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk
Authors: Leslie Skeith, Shannon M. Bates
Other posts featuring Eric Topol on Hemostasis Today.
-
Apr 17, 2026, 14:30Paschalis Evangelidis: A New Way to Treat iTTP by Targeting the Autoimmune Process
-
Apr 17, 2026, 14:27Happy World Hemophilia Day – WFH
-
Apr 17, 2026, 13:59Donna Morelli: Personalized Cardiovascular Risk Assessment Through AI-Based Multiomics Modeling
-
Apr 17, 2026, 13:27Abdalraheim Mustafa: Comparative Analysis of Thrombophilia and Thrombocytosis in Clinical Practice
-
Apr 17, 2026, 13:25Emphasizing The Importance Of Early Diagnosis For Improving Hemophilia Care In Armenia – Yeolyan Hematology and Oncology Center
-
Apr 17, 2026, 13:05Flora Peyvandi: Key Guidance from ISTH on Pediatric Antithrombotic Therapies
-
Apr 17, 2026, 12:44Marc Carrier: A Practical Approach to Recurrent Thrombosis in Cancer Patients
-
Apr 17, 2026, 12:15Zain Khalpey: The Hidden Impact of Sex Hormones on Thrombosis and Heart Health
-
Apr 17, 2026, 09:54Andrew Aswani: How NETs Contribute to Disease and Why They Matter